Literature DB >> 21146560

Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus.

S Grund1, O Adams, S Wählisch, B Schweiger.   

Abstract

The hemagglutination inhibition (HI) assay has been the main method used to investigate immune responses to vaccination against influenza H1N1 (2009) virus. However microneutralization tests (MNT) have been shown to be more sensitive and more specific. In this study, the three methods of choice: (i) the HI assay, (ii) an ELISA-based conventional MNT and (iii) a colorimetric MNT in terms of their ability to detect antibody responses in serum pairs collected from 43 healthy individuals before and 21 days after vaccination were compared. The colorimetric MNT was established yielding intra- and inter-run imprecisions of 7.5% and 12.4%, respectively. Testing of antisera to seasonal influenza viruses demonstrated the assay to be specific for antibodies to influenza H1N1 (2009) virus. A good correlation between the three methods was found, being highest for the ELISA-MNT and the colorimetric MNT (r=0.714 for geometric mean titers (GMT) and r=0.695 for titer increases). Similar rates of fourfold titer increases were detected: 95.3% in the ELISA-MNT vs. 93.0% in colorimetric MNT and 95.3% in HI assay. The ELISA-based MNT demonstrated the highest titer range leading to the highest postvaccination GMT and the highest titer increase (>50-fold). The lowest GMTs were measured with the HI assay, while the colorimetric MNT detected the highest GMT in prevaccination sera. Taken together, similar seroconversion rates were obtained with the three assays. The ELISA-MNT appeared to be the best method to compare absolute pre- and postvaccination GMTs. The colorimetric MNT, being less labour-intensive than the ELISA-MNT, seems to be a suitable tool in vaccination studies.
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146560     DOI: 10.1016/j.jviromet.2010.11.024

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  23 in total

1.  Subtyping influenza A virus with monoclonal antibodies and an indirect immunofluorescence assay.

Authors:  Jennifer Johnson; Angela Higgins; Adriana Navarro; Yung Huang; Frank L Esper; Nicole Barton; Derek Esch; Carl Shaw; Paul D Olivo; Lynn Yihong Miao
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Immunological characterization of monoclonal antibodies used in rapid influenza diagnostic test for detection of the 2009 pandemic influenza A(H1N1)pdm09 infection.

Authors:  Hwajung Yi; Mi-Seon Lee; Joo-Yeon Lee; Hae Kyung Lee; Chun Kang
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

3.  Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.

Authors:  Puja Van Epps; Terrence Tumpey; Melissa B Pearce; Hana Golding; Patricia Higgins; Thomas Hornick; Christopher Burant; Brigid M Wilson; Richard Banks; Stefan Gravenstein; David H Canaday
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

4.  Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine.

Authors:  Alexander W Kay; Nicholas L Bayless; Julia Fukuyama; Natali Aziz; Cornelia L Dekker; Sally Mackey; Gary E Swan; Mark M Davis; Catherine A Blish
Journal:  J Infect Dis       Date:  2015-03-04       Impact factor: 5.226

5.  Immune senescence in old and very old rhesus monkeys: reduced antibody response to influenza vaccination.

Authors:  Christopher L Coe; Gabriele R Lubach; Jeanne Kinnard
Journal:  Age (Dordr)       Date:  2012-01-10

6.  Detection of influenza antigenic variants directly from clinical samples using polyclonal antibody based proximity ligation assays.

Authors:  Brigitte E Martin; Kun Jia; Hailiang Sun; Jianqiang Ye; Crystal Hall; Daphne Ware; Xiu-Feng Wan
Journal:  Virology       Date:  2014-12-26       Impact factor: 3.616

7.  Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.

Authors:  Undine Ott; Andreas Sauerbrei; Jeannette Lange; Anna Schäfler; Mario Walther; Gunter Wolf; Peter Wutzler; Roland Zell; Andi Krumbholz
Journal:  Med Microbiol Immunol       Date:  2012-02-17       Impact factor: 3.402

8.  T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.

Authors:  Junwei Li; Maria T Arévalo; Yanping Chen; Shan Chen; Mingtao Zeng
Journal:  Int J Infect Dis       Date:  2014-08-27       Impact factor: 3.623

9.  L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.

Authors:  Yang Wang; Yunhua Lv; Xuefeng Niu; Ji Dong; Pei Feng; Qinming Li; Wei Xu; Jiashun Li; Chufang Li; Jiahui Li; Jia Luo; Zhixia Li; Yichu Liu; Yee-Joo Tan; Weiqi Pan; Ling Chen
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

10.  Design and Proof-of-Concept Use of a Circular PMMA Platform with 16-Well Sample Capacity for Microwave-Accelerated Bioassays.

Authors:  Muzaffer Mohammed; Kadir Aslan
Journal:  Nano Biomed Eng       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.